Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized TrialMatthew J. Ellis, M. Borgs|Journal of Clinical Oncology|2001Cited by 1.1k
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter studyW. Eiermann, Semiglazov Vf, Justus Appfelstaedt et al.|Annals of Oncology|2001Cited by 714